GlaxoSmithKline Opens Cape Town Drug Plant

GlaxoSmithKline has opened a new $3 million facility in Cape Town, South Africa, that will produce medicine to treat the debilitating disease lymphatic filariasis.

MORE ON THIS TOPIC